Firebrick Pharma LimitedASX: FRE

Firebrick starts Phase 3 common cold trial of Nasodine

May 3, 2022 at 7:42 AM UTC · Issued by Firebrick Pharma Limited

Firebrick Pharma Ltd has released a press release.

View Attachment